Trailing-twelve-month (TTM) revenue is $883.16 Million with a year-over-year growth of +5.79%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $219,017,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q3 FY2026Period ended 2025-12-31 | $250,683,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q4 FY2026Period ended 2026-03-31 | $203,035,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q1 FY2027Period ended 2026-06-30 | $210,423,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $883,158,000 |
Current P/S: $2,986,887,898 market capitalization ÷ $883,158,000 TTM revenue = 3.38x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:15:26.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $210.42M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:17:50.869Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Product | $378M | $410M | $546M | $360M | $360M | $370M |
| Service | $454M | $445M | $592M | $469M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Asia | $57M | $65M | $62M | $65M | $64M | $63M |
| Europe | $160M | $165M | $146M | $147M |
$883.16M
$883.16 Million
+5.79%
vs. $834.82M a year ago (TTM)
+1.06%
5 Year compound annual growth rate
1 Year
+5.79%
3 Year
(1.24%)
5 Year
+1.06%
10 Year
(2.38%)
15 Year
+7.78%
20 Year
+11.62%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $859.48M | +$36.80M | +4.47% |
| 2025 | $822.68M | ($6.78M) | (0.82%) |
| 2024 | $829.46M | ($85.08M) | (9.30%) |
| 2023 | $914.53M | +$58.95M | +6.89% |
| 2022 | $855.58M | +$24.29M | +2.92% |
| 2021 |
TTM Growth
+5.79%
3-Year CAGR
(1.24%)
5-Year CAGR
+1.06%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:17:50.869Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $463M |
| $489M |
| $159M |
| Rest Of World | $130M | $124M | $124M | $147M | $137M | $163M |
|---|
| UNITED STATES | $484M | $501M | $583M | $470M | $465M | $474M |
|---|
| $831.28M |
| ($60.54M) |
| (6.79%) |
| 2020 | $891.82M | ($18.10M) | (1.99%) |
| 2019 | $909.92M | ($76.87M) | (7.79%) |
| 2018 | $986.79M | ($175.32M) | (15.09%) |
| 2017 | $1.16B | +$206.69M | +21.63% |
